文献速递头颈外科

头颈癌放疗患者体成分指标与总生存的关联

Body Composition Metrics and Overall Survival in Head and Neck Cancer Radiotherapy.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2026-10-08

这项单中心回顾性队列研究纳入1187例接受根治性放疗的头颈癌患者,通过自动三维软组织表型分析发现,较高BMI与总生存改善相关,但主要反映皮下脂肪增加而非肌肉增长;影像亚组中骨骼肌较高与生存改善相关,肌肉间脂肪较高则独立增加死亡风险。

要点

  • 较高BMI(超重/肥胖)与头颈癌放疗患者总生存改善相关。
  • 自动CT三维分型显示骨骼肌较高与生存改善独立相关。
  • 肌肉间脂肪较高独立增加死亡风险,提示风险分层新指标。

核心结论

  • 较高BMI与头颈癌放疗患者总生存改善相关,但主要反映皮下脂肪增加而非肌肉增长。
  • 骨骼肌较高与总生存改善独立相关,肌肉间脂肪较高则独立增加死亡风险。

研究设计与样本

  • 单中心 tertiary academic referral center 的回顾性队列研究。
  • 主要临床队列1187例(中位年龄64.0岁,范围5.0-100.0;女性323例[27.2%],男性864例[72.8%]),影像亚组659例(55.5%)。
  • 暴露为基线BMI及自动三维容积软组织指标,主要结局为总生存,采用多变量Cox比例风险模型。

主要发现

  • 超重与总生存改善相关(HR 0.70;95% CI 0.56-0.89),肥胖亦相关(HR 0.67;95% CI 0.50-0.89)。
  • 容积分析显示BMI相关扩大主要与皮下脂肪增加相关,而非肌肉增长。
  • 影像亚组中骨骼肌较高与总生存改善相关(HR 0.67;95% CI 0.50-0.89;P = .001)。
  • 肌肉间脂肪较高独立增加死亡风险(HR 1.28;95% CI 1.03-1.58;P = .02)。

临床怎么用

  • 可利用常规放疗前CT自动提取体成分指标,辅助治疗前风险分层。
  • 识别骨骼肌低或肌肉间脂肪高的脆弱患者,考虑针对性支持治疗。
  • BMI单独不足以反映体成分风险,需结合三维软组织表型综合评估。

局限性

  • 单中心回顾性设计,影像亚组仅占55.5%,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Advancing the prognostication of patients with head and neck cancer who are undergoing radiotherapy may guide clinicians to better individualize support throughout oncologic treatment. OBJECTIVE: To evaluate how automated 3-dimensional soft tissue phenotyping, as extracted from routine computed tomography (CT) scans, provides deeper biological granularity into body composition and mortality risk and examine the prognostic utility of baseline body mass index. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study evaluated a consecutive sample of patients who were receiving conventionally fractionated definitive-intent radiotherapy for head and neck cancer between January 1, 2014, and December 31, 2024, at a single-center tertiary academic referral center. Cohort filtering was applied to exclude palliative, abbreviated, or nonstandard treatment regimens. Data were analyzed from October 2025 to May 2026. EXPOSURES: Baseline body composition metrics, including body mass index and 3-dimensional volumetric soft tissue indices, extracted automatically from pretreatment CT simulation scans using an open-source deep learning segmentation pipeline. MAIN OUTCOMES AND MEASURES: The primary outcome was overall survival. Multivariable Cox proportional hazards models were used to assess the independent prognostic associations of baseline body mass index and volumetric soft tissue indices, controlling for standard clinical confounders. RESULTS: The primary clinical cohort comprised 1187 patients (median [range] age, 64.0 [5.0-100.0] years; 323 female individuals [27.2%] and 864 male individuals [72.8%]), with an imaging subcohort of 659 patients (55.5%). While elevated body mass index categories were associated with overall survival (overweight: hazard ratio [HR], 0.70; 95% CI, 0.56-0.89; obesity: HR, 0.67; 95% CI, 0.50-0.89), a volumetric analysis revealed that this expansion was disproportionately associated with subcutaneous adiposity gain rather than muscle growth. In the imaging subcohort, elevated skeletal muscle was associated with improved overall survival (HR, 0.67; 95% CI, 0.50-0.89; P = .001). Conversely, elevated intermuscular adiposity was independently associated with an increased mortality risk (HR, 1.28; 95% CI, 1.03-1.58; P = .02). CONCLUSIONS AND RELEVANCE: The results of this cohort study suggest that higher body mass index was associated with improved overall survival. Automated volumetric CT phenotyping revealed that higher skeletal muscle and lower intermuscular adiposity were also associated with improved survival outcomes. This scalable, opportunistic framework may guide pretreatment risk stratification to identify vulnerable patients who may benefit from targeted supportive care.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Jank E, Bang C, Raj VB, et al. Body Composition Metrics and Overall Survival in Head and Neck Cancer Radiotherapy. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 42848385. doi:10.1001/jamaoto.2026.2951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。